The Mir-19 medication, designed to prevent and treat coronavirus, is suitable for inhalation and nasal administration. It halts virus replication and prevents the most severe forms of the infection, as well as pneumonitis and the acute respiratory distress syndrome that the infection causes. Read more
Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.